ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Pulmonary fibrosis,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
2,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
2,2,Headache,Headaches NEC,Headaches,Nerv,N
3,1,Clumsiness,Dyskinesias and movement disorders NEC,Movement disorders (incl parkinsonism),Nerv,N
3,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
4,1,Hepatocellular injury,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
4,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
5,2,Conjunctival oedema,"Conjunctival infections, irritations and inflammations","Ocular infections, irritations and inflammations",Eye,N
5,3,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
5,4,Headache,Headaches NEC,Headaches,Nerv,N
6,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
6,2,Gingival pain,"Gingival disorders, signs and symptoms NEC",Dental and gingival conditions,Gastr,N
6,3,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
6,4,Nasal congestion,Nasal congestion and inflammations,Upper respiratory tract disorders (excl infections),Resp,N
6,5,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
7,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
8,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
8,2,Headache,Headaches NEC,Headaches,Nerv,N
8,3,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
9,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
9,2,Cyanosis,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
9,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
10,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
10,2,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
10,3,Headache,Headaches NEC,Headaches,Nerv,N
11,1,Gynaecomastia,Breast disorders NEC,Breast disorders,Repro,N
11,2,Sexual dysfunction,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
12,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
12,2,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
13,1,Jaundice cholestatic,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
14,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
14,2,Radiation pneumonitis,Radiation injuries,Injuries by physical agents,Inj&P,Y
14,3,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
16,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
17,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
18,1,Coagulopathy,Coagulopathies,Coagulopathies and bleeding diatheses (excl thrombocytopenic),Blood,N
18,2,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
19,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
19,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
19,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
19,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
20,1,Generalised tonic-clonic seizure,Generalised tonic-clonic seizures,Seizures (incl subtypes),Nerv,N
21,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
22,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
22,2,Headache,Headaches NEC,Headaches,Nerv,N
22,3,Hypertension,Vascular hypertensive disorders NEC,Vascular hypertensive disorders,Vasc,N
22,4,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
23,1,Pain in extremity,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
24,1,Bone marrow failure,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
25,1,Autoimmune haemolytic anaemia,Anaemias haemolytic immune,Haemolyses and related conditions,Blood,N
25,2,Coombs direct test positive,Blood grouping and cross-matching analyses,Haematology investigations (incl blood groups),Inv,N
25,3,Immune thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
25,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
25,5,Polychromasia,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
25,6,Reticulocytosis,Red blood cell abnormal findings NEC,Red blood cell disorders,Blood,N
25,7,Spherocytic anaemia,Red cell membrane and enzyme abnormalities,Haemolyses and related conditions,Blood,N
26,1,Anisocoria,Pupil disorders,Ocular neuromuscular disorders,Eye,N
26,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
26,3,Wound secretion,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
27,1,Eye pain,Ocular disorders NEC,Eye disorders NEC,Eye,N
27,2,Oral pain,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
27,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
27,4,Pain in jaw,Bone related signs and symptoms,Bone disorders (excl congenital and fractures),Musc,N
27,5,Restless legs syndrome,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
28,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
29,1,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
30,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
31,1,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
32,1,Brain herniation,Cerebral injuries NEC,Injuries NEC,Inj&P,N
32,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
32,3,Cerebral infarction,Central nervous system haemorrhages and cerebrovascular accidents,Central nervous system vascular disorders,Nerv,Y
33,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
33,2,Status epilepticus,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
34,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
35,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
35,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
35,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
36,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
36,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
36,3,Implant site necrosis,Implant and catheter site reactions,Administration site reactions,Genrl,N
36,4,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
36,5,Pneumocephalus,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
37,1,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
37,2,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
37,3,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
38,1,Herpes zoster,Herpes viral infections,Viral infectious disorders,Infec,N
39,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
40,1,Pneumocephalus,Neurological and psychiatric procedural complications,Procedural related injuries and complications NEC,Inj&P,N
41,1,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
42,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
43,1,Hemiparesis,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
43,2,Neuropathy peripheral,Peripheral neuropathies NEC,Peripheral neuropathies,Nerv,N
43,3,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
44,1,CNS ventriculitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
44,2,Meningitis chemical,Chemical injuries,"Exposures, chemical injuries and poisoning",Inj&P,N
44,3,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
45,1,Cerebrospinal fluid retention,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
45,2,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
46,1,Acute myelomonocytic leukaemia,Leukaemias acute myeloid,Leukaemias,Neopl,Y
47,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
47,2,Monoplegia,Paralysis and paresis (excl cranial nerve),Movement disorders (incl parkinsonism),Nerv,N
47,3,Muscle twitching,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
47,4,White blood cell count increased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
48,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
48,2,Epstein-Barr virus infection reactivation,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
48,3,Pneumothorax,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
48,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
48,5,Pulmonary hilum mass,Mediastinal disorders,Thoracic disorders (excl lung and pleura),Resp,N
48,6,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
49,1,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
50,1,Cerebrospinal fluid leakage,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
50,2,Wound decomposition,Non-site specific procedural complications,Procedural related injuries and complications NEC,Inj&P,N
51,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
51,2,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
51,3,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
52,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
53,1,Haematoma,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,Y
54,1,Aphasia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
54,2,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
54,3,Wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
55,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,Y
55,2,Pupil fixed,Pupil disorders,Ocular neuromuscular disorders,Eye,N
56,1,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
57,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
57,2,Seizure,Seizures and seizure disorders NEC,Seizures (incl subtypes),Nerv,N
58,1,Abscess,Infections NEC,Infections - pathogen unspecified,Infec,N
59,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
60,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
60,2,Headache,Headaches NEC,Headaches,Nerv,N
60,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
61,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,Y
62,1,Malignant neoplasm progression,Neoplasms malignant site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
63,1,Postoperative wound infection,Infections NEC,Infections - pathogen unspecified,Infec,N
64,1,Haemorrhage,Haemorrhages NEC,Vascular haemorrhagic disorders,Vasc,N
65,1,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
66,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
66,2,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
66,3,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
67,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
67,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
67,3,Non-Hodgkin's lymphoma,Non-Hodgkin's lymphomas NEC,Lymphomas non-Hodgkin's unspecified histology,Neopl,Y
67,4,Pancytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
67,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
68,1,Product administered to patient of inappropriate age,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
69,1,Brain oedema,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
70,1,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
70,2,Intracranial pressure increased,Increased intracranial pressure disorders,Increased intracranial pressure and hydrocephalus,Nerv,N
71,1,Cytomegalovirus infection reactivation,Cytomegaloviral infections,Viral infectious disorders,Infec,N
71,2,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
71,3,Executive dysfunction,Cognitive and attention disorders and disturbances NEC,Cognitive and attention disorders and disturbances,Psych,N
71,4,Memory impairment,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
72,1,Multiple organ dysfunction syndrome,General signs and symptoms NEC,General system disorders NEC,Genrl,Y
72,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
72,3,Pneumonia klebsiella,Klebsiella infections,Bacterial infectious disorders,Infec,N
73,1,Abdominal lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
73,2,Biliary obstruction,Obstructive bile duct disorders (excl neoplasms),Bile duct disorders,Hepat,N
73,3,Cholecystitis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
73,4,Retroperitoneal lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
73,5,Richter's syndrome,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
74,1,Hodgkin's disease refractory,Hodgkin's disease NEC,Lymphomas Hodgkin's disease,Neopl,N
74,2,Therapy partial responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
75,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
75,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
75,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
76,1,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
76,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
76,3,Thrombocytopenia,Thrombocytopenias,Platelet disorders,Blood,N
77,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
77,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
77,3,Presyncope,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
78,1,Cytopenia,Marrow depression and hypoplastic anaemias,Anaemias nonhaemolytic and marrow depression,Blood,N
79,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
79,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
79,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
79,4,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
79,5,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
79,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
80,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
80,2,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
80,3,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
81,1,Infertility,Sexual function and fertility disorders NEC,Sexual function and fertility disorders,Repro,N
82,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
82,2,Mucosal inflammation,Mucosal findings abnormal,General system disorders NEC,Genrl,N
83,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
83,2,H1N1 influenza,Influenza viral infections,Viral infectious disorders,Infec,N
83,3,Hypogammaglobulinaemia,Immunodeficiency disorders NEC,Immunodeficiency syndromes,Immun,N
83,4,Lower respiratory tract infection,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
83,5,Lymphopenia,Leukopenias NEC,White blood cell disorders,Blood,N
83,6,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,N
83,7,Pneumonia bacterial,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
83,8,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
83,9,Respiratory tract infection,Infections NEC,Infections - pathogen unspecified,Infec,N
84,1,Cytomegalovirus enterocolitis,Cytomegaloviral infections,Viral infectious disorders,Infec,N
84,2,Gastrointestinal inflammation,Gastrointestinal inflammatory disorders NEC,Gastrointestinal inflammatory conditions,Gastr,N
84,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
85,1,Bronchopulmonary aspergillosis,Aspergillus infections,Fungal infectious disorders,Infec,Y
86,1,Pneumonia,Lower respiratory tract and lung infections,Infections - pathogen unspecified,Infec,Y
87,1,Herpes simplex,Herpes viral infections,Viral infectious disorders,Infec,N
87,2,Hyperkalaemia,Potassium imbalance,Electrolyte and fluid balance conditions,Metab,N
87,3,Mouth haemorrhage,Oral soft tissue haemorrhages,Oral soft tissue conditions,Gastr,N
87,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
87,5,Pathogen resistance,Infections NEC,Infections - pathogen unspecified,Infec,N
87,6,Renal impairment,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
87,7,Stomatitis,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
87,8,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
88,1,Organising pneumonia,Parenchymal lung disorders NEC,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
89,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
89,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
90,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
90,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
91,1,Intestinal obstruction,Gastrointestinal stenosis and obstruction NEC,Gastrointestinal stenosis and obstruction,Gastr,N
91,2,Neutropenic sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
92,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
92,2,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
92,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
92,4,Pharyngeal disorder,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
92,5,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
92,6,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,Y
93,1,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
93,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
93,3,Oropharyngeal pain,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
93,4,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
93,5,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
93,6,Tonsillar hypertrophy,Pharyngeal disorders (excl infections and neoplasms),Upper respiratory tract disorders (excl infections),Resp,N
94,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
95,1,Acute respiratory distress syndrome,Pulmonary oedemas,Lower respiratory tract disorders (excl obstruction and infection),Resp,N
95,2,COVID-19,Coronavirus infections,Viral infectious disorders,Infec,N
96,1,Intentional product use issue,Intentional product use issues,Off label uses and intentional product misuses/use issues,Inj&P,N
96,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
96,3,Swollen tongue,Tongue signs and symptoms,Tongue conditions,Gastr,N
97,1,Device related sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
98,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
99,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
99,2,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
100,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
100,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
101,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
101,2,Epstein-Barr virus infection,Epstein-Barr viral infections,Viral infectious disorders,Infec,N
101,3,Post transplant lymphoproliferative disorder,Lymphoproliferative disorders NEC (excl leukaemias and lymphomas),Haematopoietic neoplasms (excl leukaemias and lymphomas),Neopl,N
102,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
103,1,Diffuse large B-cell lymphoma recurrent,Diffuse large B-cell lymphomas,Lymphomas non-Hodgkin's B-cell,Neopl,N
103,2,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
103,3,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,1,Adenoviral encephalitis,Adenoviral infections,Viral infectious disorders,Infec,N
104,2,Adenovirus infection,Adenoviral infections,Viral infectious disorders,Infec,N
104,3,Death,Death and sudden death,Fatal outcomes,Genrl,Y
104,4,Depressed level of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
104,5,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
104,6,Encephalitis,Central nervous system and spinal infections,Infections - pathogen unspecified,Infec,N
104,7,Staphylococcal infection,Staphylococcal infections,Bacterial infectious disorders,Infec,N
105,1,Disease progression,General signs and symptoms NEC,General system disorders NEC,Genrl,N
105,2,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
105,3,Therapeutic product effect incomplete,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
